| Export to Excel |
| |
ACTIVE SURVEILLANCE
- A study of active surveillance for early prostate cancer
| Open | not specified | No |
| |
BiPAS
- The Birmingham Prostatic Neoplasms Association Study - A genetic and environmental case control study on prostate cancer in Birmingham
| Open | Observational | No |
| |
BUMPS
- Behavioural Urinary Management for Prostate Symptoms: A phase II trial for testing feasibility of a self-management intervantion for urinary problems following prostate radiotherapy
| Closed | Interventional | N/A |
| |
Cardiovascular Prostate Study
- An open study of cardiovascular and osteoporotic risk factors in patients undergoing androgen deprivation therapy for prostate cancer.
| Closed | Observational | N/A |
| 97182923 |
CHHIP
- Conventional or Hypofractionated High Dose Intensity Modulated Radiotherapy for Prostate Cancer
| Open | Interventional | No |
| |
Coping with Cancer
- Socio-economic Status and Coping with Cancer – Examining the Experience of People Recently Diagnosed with Cancer
| Closed | Observational | N/A |
| |
CV247
- A randomised double-blind local phase III study of CV247 vs salicyclic acid in early prostate cancer
| Closed | Interventional | N/A |
| 13255144 |
DA v DAS in prostate cancer
- A Randomised Phase III Trial of Dexamethasone and Aspirin (DA) Versus Dexamethasone, Diethylstilbestrol and Aspirin (DAS) in Locally Advanced or Metastatic Cancer of the Prostate
| Closed | Interventional | N/A |
| |
DB4
- Cancer Research UK Phase 1 Trial of 99mTc Demobesin-4 (99mTc DB4) given once via bolus intravenous injection for imaging of prostate cancer
| in Set-up | Interventional | No |
| |
EORTC 22991
- Three Dimensional Conformal Radiotherapy / Intensity Modulated Radiotherapy alone vs Three Dimensional Conformal Radiotherapy / Intensity Modulated Radiotherapy plus adjuvant hormonal therapy in localised T1b-c, T2a, N0, M0 prostatic carcinoma.
| Closed | Interventional | N/A |
| |
EORTC 30985
- Intermittent androgen deprivation in patients with stage D2 prostate cancer-Phase III
| Closed | Interventional | N/A |
| |
Flomax
- Prophylactic Flomax in prostate cancer
| Closed | Interventional | N/A |
| 69304414 |
FOCAL - HIFU
- An Evaluation of Focal Ablation Therapy using High-Intensity Focused Ultrasound in the Treatment of Localized Adenocarcinoma of the Prostate
| Open | Interventional | No |
| 25145525 |
HEMI-HIFU
- An evaluation of hemi-ablation therapy using high-Intensity focused ultrasound in the treatment of localised adenocarcinoma of the prostate
| Closed | Interventional | N/A |
| |
High Dose Rhenium
- High Activity Rhenium-186 HEDP with peripheral blood stem cell support in patients with bony metastases in prostate cancer.
| Closed | Interventional | N/A |
| |
HIPRO
- Hypofractionated Dose Escalation utilising Intensity Modulated Radiotherapy (IMRT) in Carcinoma of the Prostate
| Closed | Interventional | N/A |
| |
IHT in prostate cancer
- Intermittent androgen deprivation in patients with prostate cancer
| Closed | Interventional | N/A |
| |
IMPACT
- Identification of Men with a genetic predisposition to ProstAte Cancer: Targeted Screening in BRCA1/2 mutation carriers and controls - IMPACT
| Open | Observational | Yes, within and outside lead country |
| 22761545 |
Intercontinental
- INTERmittent or CONTINuos ENdocrine Therapy After failure in Localised prostate cancer.
| Closed | Interventional | N/A |
| |
Lesion Control HIFU
- An Evaluation of Lesion Control using Focal Ablation with High Intensity Focused Ultrasound in the Treatment of Non-Metastatic Progressive Prostate Cancer
| Open | Interventional | No |
| 59410552 |
LOPERA
- Randomised controlled trial of laparoscopic, open and robot assisted prostatectomy as treatment for organ-confined prostate cancer.
| Open | Interventional | No |
| 87696430 |
MAPS
- Conservative treatment for urinary incontinence in Men After Prostate Surgery (MAPS): multicentre randomised controlled trial of pelvic floor muscle training, biofeedback and bladder training
| Closed | Interventional | N/A |
| |
Matched pair QoL/Toxicity Study in Advanced Prostate Cancer
- Matched pair study to assess the quality of life and toxicity in patients with carcinoma of the prostate undergoing external beam radiotherapy plus high dose rate brachytherapy boost compared with patients receiving conformal external beam radiotherapy alone
| Open | Observational | No |
| |
NCRN001 (Onyvax P)
- NCRN001 (Onyvax P)
| Closed | Interventional | N/A |
| |
NCRN018 - INDUSTRY STUDY
- A Multicenter, Randomized, Double-Blind Study Comparing The Efficacy And Safety Of Aflibercept Versus Placebo Administered Every 3 Weeks In Patients Treated With Docetaxel / Prednisone For Metastatic Androgen-Independent Prostate Cancer
| Closed | Interventional | N/A |
| |
NCRN049
- A multicenter, randomized, double-blind, phase 3 study of sunitinib plus prednisone versus prednisone in patients with progressive metastatic hormone-refractory prostate cancer after failure of a docetaxel-based chemotherapy regimen
| Open | Interventional | No |
| |
NCRN078
- An Open-label, Multicenter, Phase 2 Study of Single-agent CNTO 888 (an anti-CCL2 Monoclonal Antibody) for the Treatment of Subjects with Metastatic Castrate-Resistant Prostate Cancer
| Closed | Observational | N/A |
| |
NCRN102
- A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide With or Without Deforolimus in Men With Asymptomatic, Metastatic Castrate-Resistant Prostate Cancer
| Open | Interventional | No |
| |
NCRN111
- A Randomized, Double Blind, Phase 3 Trial Comparing Ipilimumab vs. Placebo Following Radiotherapy in Subjects with Castration Resistant Prostate Cancer That Have Received Prior Treatment with Docetaxel
| Open | Interventional | No |
| |
NCRN112
- A Randomised Double Blind, Placebo-controlled Study to Evaluate the Effect on Unassisted Erectile Function of the Early use of Tadalafil 5mg Once a day and Tadalafil 20mg On Demand Treatment for 9 months in Subjects Undergoing Bilateral Nerve Sparing Radical Prostatectomy (BNSRP).
| Open | Interventional | -unknown- |
| |
NCRN121
- A PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DOCETAXEL AND PREDNISONE WITH OR WITHOUT LENALIDOMIDE IN SUBJECTS WITH CASTRATE-RESISTANT PROSTATE CANCER
| Open | Interventional | -unknown- |
| 70406718 |
PATCH
- Prostate Adenocarcinoma: TransCutaneous Hormones. A randomised-controlled trial of transcutaneous oestrogen patches versus LHRH analogues in prostate cancer.
| Open | Interventional | Yes, within lead country only |
| |
PCSS
- The Prostate Cancer Symptoms Study
| Closed | Interventional | N/A |
| |
Pelvic IMRT for prostate cancer
- A Phase 1 dose escalation study of the use of intensity modulated radiotherapy
(IMRT) to treat the prostate and pelvic nodes in patients with prostate cancer
| Closed | Interventional | N/A |
| 24991896 |
PR07
- A Randomised trial of Hormone Therapy plus Radical radiotherapy versus Hormone Therapy alone in Non-Metastatic Prostate Cancer
| Closed | Interventional | N/A |
| |
PRECIOUS
- Improving the assessment and recording of cancer treatment effects
| Open | Observational | No |
| |
Process
- Prostate Cancer in Ethnic Subgroups: A comparative study of Incidence, Clinical Presentation and access to Health Care in the UK (Process).
| Closed | Observational | N/A |
| 95931417 |
ProDiet
- The feasibility of an RCT in dietary interventions for men at high risk of prostate cancer
| Closed | Interventional | N/A |
| |
ProMPT
- Molecular mechanisms of disease progression and the development of novel treatment strategies in advanced prostate cancer (Northern Prostate Cancer Collaborative (ProMPT))
| Open | Observational | -unknown- |
| |
ProSTART
- A PHASE III STUDY OF ACTIVE SURVEILLANCE THERAPY AGAINST RADICAL TREATMENT IN PATIENTS DIAGNOSED WITH FAVOURABLE RISK PROSTATE CANCER (START)
| Closed | Interventional | N/A |
| |
Prostate & Cognition
- An exploratory pilot study to investigate whether hormonal therapy for prostate cancer has an adverse effect on cognition
| Closed | Observational | N/A |
| 98241100 |
Prostate HDR brachytherapy boost trial
- Randomised trial of interstitial brachythearpy as a component of radical radiotherapy for localised prostatic cancer
| Closed | Interventional | N/A |
| 20141297 |
ProtecT
- The ProtecT Trial - Evaluating the effectiveness of treatment for clinically localised prostate cancer
| Closed | Interventional | N/A |
| |
Proteins CTCF and BORIS as biomarkers in breast and prostate cancers
- A study on the proteins CTCF and BORIS in breast and prostate samples: the assessment of the potential diagnostic and prognostic value of CTCF and BORIS as biomarkers in breast and prostate cancers
| Open | Observational | No |
| |
RAACS
- Rural accessibility and cancer survival
| Closed | Interventional | N/A |
| 40814031 |
RADICALS (MRC PR10)
- Radiotherapy and Androgen Deprivation In Combination After Local Surgery
| Open | Interventional | Yes, within and outside lead country |
| |
RAPPER
- Radiogenomics: assessment of polymorphisms for predicting the effects of radiotherapy
| Open | Observational | Yes, within lead country only |
| 86185157 |
RIB
- A multicentre randomised trial of single dose Radiotherapy compared to Ibandronate for localised metastatic bone pain
| Closed | Interventional | N/A |
| 47772397 |
RT01
- A Randomised Trial of High Dose Therapy in Localised Cancer of the Prostate Using Conformal Radiotherapy Techniques
| Closed | Interventional | N/A |
| 88144169 |
SABRE 1
- Surgery And Brachytherapy -
A Randomised Evaluation Randomised controlled trial of brachytherapy versus radical prostatectomy in good risk prostate cancer: a feasibility study
| Open | Interventional | No |
| |
SPIRIT
- A Randomized Trial of Radical Prostatectomy versus Brachytherapy for Patients with T1c or T2a N0 M0 Prostate Cancer
| Closed | Interventional | N/A |
| 78818544 |
Stampede
- Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy
| Open | Interventional | Yes, within and outside lead country |
| |
TAPS
- Targeted PSA screening for familial prostate cancer
| Closed | Interventional | N/A |
| 12808747 |
TRAPEZE
- A randomised phase II/III trial of docetaxel plus
prednisolone vs. docetaxel plus prednisolone plus zoledronic acid vs. docetaxel plus prednisolone plus strontium-89 vs. docetaxel plus prednisolone plus zoledronic acid plus strontium-89 in hormone refractory prostate cancer metastatic to bone.
| Open | Interventional | Yes, within and outside lead country |
| |
UK Genetic Prostate Cancer Study
- UK Genetic Prostate Cancer Study
| Open | Observational | Yes, within and outside lead country |